ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

House Passes Bill Authorizing NIH Funds; Veto Likely

August 2, 1991

New Control Grant Guidelines Include Community Resources Development

August 22, 1975

Survivors Urge Congress To Include Oral Drug Coverage In Medicare Legislation

October 11, 2002

Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing

February 27, 1981

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001